Director Inglis I Martin sells 5,691 shares of CRS at $244.54; holdings cut by -45.8%, stock down -15.9% in 90 days
Director Inglis I Martin sold 5,691 shares at $244.54 on 2025-08-18, reducing his stake from 12,423 to 6,732 shares—a -45.8% reduction in holdings. The stock is currently trading at $241.62, down -15.9% from its 52-week high of $287.42. Over 90 days, the stock has gained +4.9% despite recent weakness, suggesting the sale occurred during a period of mixed momentum. With CRS trading at a P/E of 22.01 and posting annual revenue growth of +4.2% on a $727.0M quarterly revenue base, the company shows modest but positive fundamentals. The magnitude of this reduction and the timing relative to recent price weakness warrant monitoring of broader insider activity patterns and any related disclosures.